Inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme v5
The NHS Breast Screening Programme NHSBSP is now responsible for managing the imaging surveillance of women who are assessed as being at higher risk of developing breast cancer. Their elevated risk may be due to a genetic predisposition to the disease a significant family history of breast cancer or previous supradiaphragmatic radiotherapy e.g. treatment for Hodgkin’s disease .
This guideline sets out the role of a breast screening programme in relation to women at greater than average risk of breast cancer and describes the organisational arrangements that need to be in place including appropriate use of the computer system the National Breast Screening System NBSS .
Clinical GuidelinesThis guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.
The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.